Vipera ammodytes venom protein toxins

Vipera ammodytes venom protein toxins represent the complex secretome of the nose-horned viper, widely regarded as the most medically significant venomous snake in Europe. The venom's toxicity is primarily driven by ammodytoxins, which are highly potent presynaptic neurotoxic phospholipases A2 (PLA2) that disrupt neuromuscular transmission by interfering with synaptic vesicle recycling (UniProt: P00630). Beyond neurotoxicity, the venom contains a diverse array of snake venom metalloproteinases (SVMPs) and serine proteases (SVSPs) that cause systemic hemorrhage and profound coagulopathy by degrading vascular basement membranes and depleting clotting factors (PubMed: 25448275). Clinical management of envenomation relies on the timely administration of antivenoms, which consist of equine or ovine-derived antibody fragments designed to neutralize these specific protein families (StatPearls: NBK431063). Research into these toxins also explores their potential as templates for drug design, particularly in the fields of anticoagulation and analgesia, due to their high specificity for vascular and neural targets (PubMed: 23103301).

Other names

Nose-horned viper venomVipera ammodytes venomAmmodytes toxinsVipera ammodytes venom proteins

Neutralization of toxic enzymatic and non-enzymatic activities through the binding of specific antibody fragments (Fab or F(ab')2), which prevents the toxins from interacting with their physiological targets such as the neuromuscular junction or vascular endothelium.